“…Because Sertoli cells also seendothelial growth factor (VEGF) (25,34,37,39,40,45,50), basic fibroblast growth factor (bFGF) (4,30,31,67), crete angiogenic factors (13,23), it is possible that SC ET retain this functional ability and stimulate neovasculariplatelet-derived growth factor (PDGF) (40), insulin-like growth factor-1 (IGF-1) (40), fractalkine (9,63), and tuzation of newly transplanted cells and tissues, thereby enhancing graft survival and transplantation protocol mor necrosing factor-α (TNF-α) (1,29,32,67). Increasing the amounts of these types of growth factors at the efficacy.…”